Fig. 2From: Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in ChinaMRI imaging of two representative patients with TSC-AML in everolimus/sirolimus groups during follow-upBack to article page